SCHEMBL6203770

SCHEMBL6203770

Clc1ncc(CCCBr)c(Cl)n1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203090 0.88 KDM4E (0.31)
SCHEMBL6206164 0.81 PDXK (0.35) SIRT2
SCHEMBL7966254 0.79 KDM4E (0.32)
SCHEMBL791580 0.79 KCNH2 (0.36)
SCHEMBL6203110 0.78 KDM4E (0.31)
SCHEMBL6219173 0.76 AURKA (0.34)
SCHEMBL6204668 0.76 PDXK (0.37)
SCHEMBL19992519 0.73 MAPT (0.33)
SCHEMBL4321200 0.73 KMT2A (0.39)
SCHEMBL30961423 0.72 KDM4E (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560832-A1 PYRIMIDO 4,5-D PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041822-A1 PYRIMIDO[4,5-D]PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed